Tizanidine

Product NDC
63629-7037
11-digit product format
636297037
Labeler code
63629
Product ID
63629-7037_a9846606-4a30-409c-9ff8-1449f24f0317
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Tizanidine
Dosage form
TABLET
Route
ORAL
Labeler
Bryant Ranch Prepack
Application
ANDA076416
Marketing category
ANDA
Marketing start
2003-12-11
Substance
TIZANIDINE HYDROCHLORIDE
Active strength
2 mg/1
Pharmacologic classes
Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Tizanidine
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
TIZANIDINE HYDROCHLORIDE2 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
UniiB53E3NMY5C
Rxcui313412

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
a0ff02d8-b711-423c-b7d1-ada00d81c743Product name120250805
9fd28b3a-d1bb-a2ce-ffa3-c3dd28536a01Product name820250313
b404127e-1c01-47bb-874e-db1e0b6bd9afProduct name420250313

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
63629-7037-12020-10-16C16284748780-19d75b9d0-da0e-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use Tizanidine Tablets, USP safely and effectively. See full prescribing information for Tizanidine Tablets, USP. Tizanidine Tablets, USP (tizanidine hydrochloride) tablets, for oral use Initial U.S. Approval: 1996
63629-7037-22020-10-16C16284748780-19d75b9d0-da0e-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use Tizanidine Tablets, USP safely and effectively. See full prescribing information for Tizanidine Tablets, USP. Tizanidine Tablets, USP (tizanidine hydrochloride) tablets, for oral use Initial U.S. Approval: 1996
63629-7037-32020-10-16C16284748780-19d75b9d0-da0e-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use Tizanidine Tablets, USP safely and effectively. See full prescribing information for Tizanidine Tablets, USP. Tizanidine Tablets, USP (tizanidine hydrochloride) tablets, for oral use Initial U.S. Approval: 1996
63629-7037-12020-01-31C16284748780-19d75b9d0-da0e-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use Tizanidine Tablets, USP safely and effectively. See full prescribing information for Tizanidine Tablets, USP. Tizanidine Tablets, USP (tizanidine hydrochloride) tablets, for oral use Initial U.S. Approval: 1996
63629-7037-22020-01-31C16284748780-19d75b9d0-da0e-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use Tizanidine Tablets, USP safely and effectively. See full prescribing information for Tizanidine Tablets, USP. Tizanidine Tablets, USP (tizanidine hydrochloride) tablets, for oral use Initial U.S. Approval: 1996
63629-7037-32020-01-31C16284748780-19d75b9d0-da0e-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use Tizanidine Tablets, USP safely and effectively. See full prescribing information for Tizanidine Tablets, USP. Tizanidine Tablets, USP (tizanidine hydrochloride) tablets, for oral use Initial U.S. Approval: 1996

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
63629-7037-1Tizanidine30 in 1 BOTTLETABLET305
63629-7037-2Tizanidine20 in 1 BOTTLETABLET205
63629-7037-3Tizanidine10 in 1 BOTTLETABLET105

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
63629-7037TIZANIDINE TABLET [BRYANT RANCH PREPACK]5Current NDC, Legacy NDC, 3 package rows20250523_73269d77-16b5-4787-9a7d-1b8688623436.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
313412tiZANidine HCl 2 MG Oral TabletPSN73269d77-16b5-4787-9a7d-1b86886234365
313412tizanidine 2 MG Oral TabletSCD73269d77-16b5-4787-9a7d-1b86886234365
313412tizanidine 2 MG (as tizanidine HCl 2.288 MG) Oral TabletSY73269d77-16b5-4787-9a7d-1b86886234365

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
63629-7037-16362970370130 TABLET in 1 BOTTLE (63629-7037-1) 30 tablet2016-06-290000-00-00NoNoCurrent
63629-7037-26362970370220 TABLET in 1 BOTTLE (63629-7037-2) 20 tablet2016-06-290000-00-00NoNoCurrent
63629-7037-36362970370310 TABLET in 1 BOTTLE (63629-7037-3) 10 tablet2016-06-290000-00-00NoNoCurrent